Qinghua Wang
Founder, GM & Executive ChairmanDr. Qinghua Wang, Ph.D., is the founder of the Group, was appointed as the chairman of the Board and the general manager of Guangzhou Innogen Pharmaceutical Group Co., Ltd. in December 2014. He was re-designated as an executive Director in October 2024. Dr. Wang has expertise in the field of metabolic diseases. Prior to founding the Group in December 2014, he dedicated several years to translational research on diabetes and metabolic diseases, serving as a postdoctoral fellow from July 1999 to June 2002, an assistant professor from October 2001 to June 2007 and an associate professor in department of physiology in the University of Toronto from July 2007 to June 2013. From June 2009 to June 2014, Dr. Wang was also appointed as the researcher of the Institute of Medical Science in the University of Toronto. Dr. Wang also held several positions at affiliated research institutes and hospitals, including as (i) a senior scientist at the Li Ka Shing Institute of Knowledge and the Division of Endocrinology and Metabolism at St. Michael’s Hospital in Canada since September 2008; (ii) an affiliate scientist to the Keenan Research Centre for Biomedical Science of St. Michael’s Hospital from March 2018 to March 2021; and (iii) the distinguished professor and doctoral supervisor of Fudan University (????) since July 2014. Dr. Wang has also been serving as a deputy director at Institute of Endocrinology and Diabetes of Huashan Hospital of Fudan University (???????????????????) since July 2014. Dr. Wang was appointed as the project manager for Major National Science and Technology Projects for New Drug Development under the National 13th Five-Year Plans (? ??????“??????”?????). Dr. Wang obtained a doctorate in biochemistry from University of Antwerp in May 1995 in Belgium.
Positions
- Company NameGuangzhou Innogen Pharmaceutical Group Co., LtdStock Code02591PositionFounder, GM & Executive Chairman
